12 Recent studies provide a direct demonstration of actions of central GLP-1 and show projections from GLP-1containing neurons in the NTS to the nucleus accumbens core and of satiation induced by injections of GLP-1 into this region of the accumbens
This pharmacokinetic profile supports the medication's mechanism of action, which includes enhancing glucose-dependent insulin secretion, suppressing inappropriate glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways
This is one reason nutrition support matters so much on these medicines
Long-Term Use of Semaglutide and Monitoring: Ahrn, B., Masmiquel, L., Kumar, H., et al
Knh mi qu khch xem thm mt s sn phm khc ti nh thuc ca chng ti: Thuc TAD 600mg/4ml c tc dng g
The combination could produce additive or even synergistic improvements in these markers, which translates directly to reduced cardiovascular risk